CME/CE Accredited Session
Sponsored by Industry
Click For Session
Session Times Listed in ET
Martin J. Abrahamson, MD, FACP
This 60 minute session entitled, Updates for Primary Care Clinicians; Pearls from the American Diabetes Association Scientific Sessions, will take place during an upcoming Pri-Med PrimaryCareNOW Virtual Conference. The faculty will discuss recent clinical trials presented at the 80th American Diabetes Association (ADA) Scientific Sessions Virtual Experience which took place from June 12-16, 2020. The faculty will highlight important updates including new data on SGLT2 inhibitors related to cardiovascular outcomes, renal outcomes, and their use in prediabetes and will also discuss the latest information on continuous glucose monitoring. Further, the faculty will walk learners through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated into these guidelines. After this meeting review, learners will be equipped to optimally manage type 2 diabetes based on these guidelines and new findings.
Associate Professor of Medicine, Harvard Medical School; Director, Division of CME, Beth Israel Deaconess Medical Center, Boston, MA
Supported by Merck & Co., Inc.
Managing Influenza: Practical Strategies For Primary Care
Pamela Kushner, MD, FAAFP | Daniel A. Solomon, MD
Is influenza going viral in your practice? This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.
Clinical Professor, University of California Irvine Medical Center; Director, Kushner Wellness Center, Los Alamitos, CA
Associate Physician, Division of Infectious Diseases, Brigham and Women's Hospital; Instructor of Medicine, Harvard Medical School, Boston, MA
Supported by Genentech
Is It Time to Reconsider Your Treatment Strategy in Your Patients With T2D?
Jeff Unger, MD, FAAFP, FACE
Explore efficacy and safety data for 2 GLP-1 RA options for adults with T2D. A data review from pivotal glycemic control trials as well as cardiovascular outcomes data will be presented.
Sponsored by Novo Nordisk
Uncontrolled Asthma: Changing the Patient Experience
Anne Marie Irani, MD
In this session, Dr. Irani will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by pairing the right medications with the right patients.
Sponsored by GlaxoSmithKline
Aarati Didwania, MD, MSCI, FACP
Microaggression are common, everyday occurrences that impact an individual’s sense of well-being. They occur because of implicit bias and can have an impact on our relationships with our patients, colleagues and on our own sense of well-being. In this session, I will discuss the concept of microaggressions including definitions and terminology through examples. I will also discuss the impact that repetitive exposure can have on an individual. I will conclude with a discussion on strategies for managing occurrences in the moment and frameworks for recognizing and reducing implicit bias.
Associate Professor of Medicine, Director of STAR Program, Northwestern University Feinberg School of Medicine, Chicago, IL
COPD: Simplifying a Complex Paradigm for Busy Clinicians
David Mannino, MD
This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.
Professor of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky College of Medicine; Founding Board Member, COPD Foundation, US Medical Expert, Respiratory Therapeutic Area,
Sponsored by GlaxoSmithKline
Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain
Paul G. Sutej, MD
1.) Understand the causes and prevalence of chronic low back pain
2.) Differentiate inflammatory back pain (IBP) from mechanical back pain
3.) Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS)
4.) Learn the importance of referring patients with IBP to a rheumatologist in a timely manner
Sponsored by AbbVie
Charles E. Argoff, MD, FABPM | Oscar A. de Leon-Casasola, MD | Katherine E. Galluzzi, DO, CMD, FACOFP
This session is designed to satisfy CME/CE requirements on Pain Management. Please check with your state licensing board for their specific requirements. Participate in this Opioid Analgesic REMS activity to earn 3.5 Medical Knowledge and Patient Safety credits in the ABIM MOC program.
Supported by Opioid Analgesic REMS Program Companies